BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34449129)

  • 21. [Transdermal therapeutic systems for drug administration].
    Hupfeld S; Gravem H
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine.
    McKenna PE; Abbate MTA; Vora LK; Sabri AH; Peng K; Volpe-Zanutto F; Tekko IA; Permana AD; Maguire C; Dineen D; Kearney MC; Larrañeta E; Paredes AJ; Donnelly RF
    ACS Appl Mater Interfaces; 2023 Jul; 15(26):31300-31319. PubMed ID: 37349320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractional derivatives in the diffusion process in heterogeneous systems: The case of transdermal patches.
    Caputo M; Cametti C
    Math Biosci; 2017 Sep; 291():38-45. PubMed ID: 28709973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
    Ham AS; Buckheit RW
    Ther Deliv; 2015 Feb; 6(2):217-29. PubMed ID: 25690088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future of the transdermal drug delivery market--have we barely touched the surface?
    Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
    Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smart Responsive Microneedles for Controlled Drug Delivery.
    Qi Z; Yan Z; Tan G; Kundu SC; Lu S
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microneedle-assisted transdermal delivery of nanoparticles: Recent insights and prospects.
    Guillot AJ; Martínez-Navarrete M; Zinchuk-Mironova V; Melero A
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1884. PubMed ID: 37041036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unconventional Passive Enhancement of Transdermal Drug Delivery: toward a Mechanistic Understanding of Penetration Enhancers Releasing from Acrylic Pressure-Sensitive Adhesive of Patches.
    Zeng L; Song W; He W; Zhang J; Wang Y; Bian J; Mao Z; Quan D; Liu J
    Pharm Res; 2020 Aug; 37(9):169. PubMed ID: 32794010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
    Perumal O; Murthy SN; Kalia YN
    Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
    Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
    J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal drug delivery.
    Guy RH
    Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifunctional Smart Skin Adhesive Patches for Advanced Health Care.
    Hwang I; Kim HN; Seong M; Lee SH; Kang M; Yi H; Bae WG; Kwak MK; Jeong HE
    Adv Healthc Mater; 2018 Aug; 7(15):e1800275. PubMed ID: 29757494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivering drugs by the transdermal route: review and comment.
    Tanner T; Marks R
    Skin Res Technol; 2008 Aug; 14(3):249-60. PubMed ID: 19159369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.
    Palmer BC; DeLouise LA
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches.
    Karve T; Dandekar A; Agrahari V; Melissa Peet M; Banga AK; Doncel GF
    Adv Drug Deliv Rev; 2024 Jul; 210():115326. PubMed ID: 38692457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.
    Polat BE; Blankschtein D; Langer R
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1415-32. PubMed ID: 21118031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal formulation for dermal and transdermal drug delivery: past, present and future.
    Nounou MI; El-Khordagui LK; Khalafallah NA; Khalil SA
    Recent Pat Drug Deliv Formul; 2008; 2(1):9-18. PubMed ID: 19075893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an intelligent, stimuli-responsive transdermal system for efficient delivery of Ibuprofen against rheumatoid arthritis.
    Khan D; Qindeel M; Ahmed N; Asad MI; Shah KU; Asim Ur Rehman
    Int J Pharm; 2021 Dec; 610():121242. PubMed ID: 34737113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.